MiRNA-based therapy for Melonama: MiRNA-203 increases the expression of ADAR1 and inhibits melanoma progression via down regulation of its target gene, 27/February/2015, 09.10 am

Molecular therapy for cancer: Tumor suppressor p53 increases the expression of oncogenic suppressor PTX3 and inhibits complement-dependent inflammation in cancer via down regulation of its target gene, 27/February/2015, 9.07 am
February 27, 2015
MiRNA-based anti-tumor immunity enhancement therapy: MiRNA-128-2 promotes anti-tumor immunity via down regulation of its target gene, 27/February/2015, 23.02
February 27, 2015
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, MiRNA-based therapy for Melonama:  MiRNA-203 increases the expression of ADAR1 and inhibits melanoma progression via down regulation of its target gene, 27/February/2015, 09.10 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Significance:  This study suggests, for the first time, that MiRNA-203, by inducing the expression of its target geneit may increase the expression of ADAR1.  Thereby, it may inhibit melanoma progression. Thus, pharmacological formulations encompassing “MiRNA-203 or its analogues” may be used in the treatment of melanoma.

Amount: $ 500*

Undisclosed information: How MiRNA-203 increases the expression of ADAR1

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Comments are closed.